Benchmark Co. analyst Bill Sutherland has maintained their neutral stance on AMN stock, giving a Hold rating yesterday.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Bill Sutherland has given his Hold rating due to a combination of factors surrounding AMN Healthcare Services’ recent strategic decisions and market conditions. The company recently sold its scheduling software, Smart Square®, to symplr for $75 million, which will help reduce its debt. However, this decision was driven by growth challenges in a competitive market, indicating potential hurdles in expanding this segment.
Additionally, while there is solid demand for travelers, unfilled orders remain high due to uncompetitive rates, although there are initial signs of improvement. The company’s financial guidance for the upcoming quarters suggests stability but not significant growth, with projected revenues in line with previous guidance and a slight decline in EBITDA margins. These factors collectively suggest a cautious approach, justifying the Hold rating as the company navigates these challenges and opportunities.
According to TipRanks, Sutherland is an analyst with an average return of -3.0% and a 39.71% success rate. Sutherland covers the Healthcare sector, focusing on stocks such as Omnicell, Select Medical, and Clinigence Holdings.